Clinical Trial Update: Drug Etiology of Aplastic Anemia and Related Dyscrasias

View source ↗

Summary

NHLBI-sponsored clinical trial evaluating etiologies of aplastic anemia and related dyscrasias has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Agranulocytosis
• Aplastic Anemia
• Purpura
• Thrombocytopenia

Snippet

Sponsor: National Heart, Lung, and Blood Institute (NHLBI) | Conditions: Blood Disease, Anemia, Aplastic | Status: COMPLETED